In 2013, the Lancet published Global Health 2035, the first report of the Commission on Investing in Health (CIH 1.0), which provided a roadmap to achieving dramatic gains in global health by 2035. A second report (CIH 2.0) was published five years later to mark the 40 year anniversary of the influential Alma Ata Declaration on “health for all.” On October 15, 2024, we will publish a third report (CIH 3.0), called “Global Health 2050,” which identifies opportunities for investment in health in the post-COVID era that can succeed despite multiple headwinds, including rising geopolitical tensions and increasingly manifest climate change.
For CIH 3.0, we have convened an international group of 49 Commissioners. Our work is guided by expert advice from a high-level Advisory Committee chaired by John-Arne Røttingen, Chief Executive Officer of the Wellcome Trust.
The CIH is chaired by former U.S. Treasury Secretary Lawrence H. Summers, President Emeritus and the Charles W. Eliot University Professor at Harvard University, and co-chaired by Dean T. Jamison, Emeritus Professor in the Institute for Global Health Sciences at the University of California, San Francisco.
The Secretariat for CIH 3.0 is housed at the Center for Policy Impact in Global Health in the Duke Global Health Institute, Duke University, and the University of Bergen Centre for Ethics and Priority Setting in Health, Norway.
Global Health 2050 Launch
The Global Health 2050 report will be launched on October 15, 2024, at a keynote event at the 2024 World Health Summit in Berlin, Germany. The launch will be chaired by Richard Horton, editor of The Lancet. It will feature two CIH 3.0 Commissioners, Angela Chang and Lia Tadesse, and two members of the CIH 3.0 Advisory Committee, Olive Shisana and Helen Clark.
Angela Chang
Associate Professor, University of Southern Denmark
Lia Tadesse
Director, Harvard Ministerial Leadership Program
Helen Clark
Board Chair, Partnership for Maternal, Newborn and Child Health
